The Office of HIV/AIDS Network Coordination (HANC) works with the HIV/AIDS Clinical Trials Networks of the U.S. National Institutes of Health (NIH) with the intent of creating a more integrated, collaborative and flexible research structure. The networks are an affiliated group of national and international medical research institutions and investigators that conduct clinical HIV/AIDS research to develop safe and effective drugs, prevention strategies, and vaccines.
A new memo from the DAIDS Office of Clinical Site Oversight (OCSO) notes minor updates to the Site Clinical Operations and Research Essentials (SCORE) Manual. These updates affect the following sections: Investigator Responsibilities, Essential Documents, Essential Documents Recordkeeping Appendix, CRS Facility Requirements, Site Activation Process, Source Documentation Requirements Appendix, and Record Retention.
The Office of HIV/AIDS Network Coordination (HANC) is recruiting for its next HANC Director. The HANC Director is responsible for managing and supervising all aspects of the activities of HANC, and reports to the principal investigators of the four NIH-funded HIV/AIDS Clinical Trial Networks and the Director of the Division of DAIDS at NIAID. View more details and apply on the Fred Hutch Careers page.
The Office of HIV/AIDS Network Coordination (HANC) programs are referred to as areas of coordination. Within each area of coordination are numerous work groups that are integral to advancing the research goals and objectives defined by the HIV/AIDS Clinical Trials Networks and the Division of AIDS.
HANC supports a number of trans-institute behavioral science groups composed of experts that are working to advance research and clinical trials through cross-network collaboration.
HANC supports Community Partners, The Legacy Project, and the COVID-19 CAB coalition to achieve representation and build relationships with historically underrepresented communities in clinical research.
HANC supports cross-network working groups for network leadership, communications, data management centers, performance evaluation, and site coordinators to promote greater information sharing, collaboration, and process standardization.
HANC supports several cross-network laboratory working groups and committees with the aim of harmonizing processes and procedures, ensuring standard quality assurance for protocol-specified assays and laboratory preparedness for network clinical trials.
The NIDA HIV Research Program invites you to a symposium with awardees of the Avant-Garde Awards Program for HIV/AIDS and Substance Use Disorder Research, supporting innovative research into new areas of HIV prevention and treatment among people who use drugs. Click here for more information.
The 2022 HPTN Annual Meeting will take place at the JW Marriott June 4-8, 2022 in Washington D.C. Those unable to attend in person will be able to participate through a virtual option. The meeting will feature several plenaries, HIV and COVID-19 prevention research presentations and discussions, and interactive Q&A sessions.
Featured speaker is Dr. Dominika Seidman, Obstetrician, Gynecologist and Assistant Professor, Ob/Gyn, Reproductive Sciences at the University of California San Francisco School of Medicine.
Working together, we can be the generation to end the HIV/AIDS epidemic. Know the facts, spread the word, volunteer for a study, or join a community advisory board.